Novel ATP-Competitive MEK Inhibitor E6201 Is Effective against Vemurafenib-Resistant Melanoma Harboring the MEK1-C121S Mutation in a Preclinical Model
暂无分享,去创建一个
K. Sawada | K. Okamoto | Kotaro Kodama | N. Miyamoto | Masao Iwata | Kazuma Takase | Y. Minoshima | Y. Narita | Megumi Ikemori Kawada